# Object Record 1
**objectId:** dashboard-item-1759906076097-medications-timeline
**type:** component
**componentType:** Medications Timeline
**description:** 
**content title:** Patient Medications Timeline
**content component:** MedicationsTimeline
**content props encounters 0 encounter no:** 1
**content props encounters 0 date:** 2015-08-10
**content props encounters 0 type:** Rheumatology Initial Consult
**content props encounters 0 provider:** Dr. Elizabeth Hayes
**content props encounters 0 diagnosis:** Seropositive Rheumatoid Arthritis (active)
**content props encounters 0 medications 0:** Methotrexate 10mg weekly
**content props encounters 0 medications 1:** Folic Acid 5mg weekly
**content props encounters 0 notes:** Started MTX therapy with folic acid supplementation
**content props encounters 1 encounter no:** 2
**content props encounters 1 date:** 2016-02-20
**content props encounters 1 type:** General Practice
**content props encounters 1 provider:** GP
**content props encounters 1 diagnosis:** Stable RA on MTX
**content props encounters 1 medications 0:** Methotrexate 10mg weekly
**content props encounters 1 medications 1:** Folic Acid 5mg weekly
**content props encounters 1 notes:** Good RA control on MTX 10 mg weekly; no MTX side effects
**content props encounters 2 encounter no:** 3
**content props encounters 2 date:** 2018-09-05
**content props encounters 2 type:** General Practice
**content props encounters 2 provider:** GP
**content props encounters 2 diagnosis:** New essential hypertension; RA stable; plan MTX dose increase
**content props encounters 2 medications 0:** Methotrexate 20mg weekly
**content props encounters 2 medications 1:** Folic Acid 5mg weekly
**content props encounters 2 medications 2:** Lisinopril 10mg daily
**content props encounters 2 notes:** Elevated BP readings 145–155/90–95; MTX increased to 20mg
**content props encounters 3 encounter no:** 4
**content props encounters 3 date:** 2021-03-15
**content props encounters 3 type:** General Practice
**content props encounters 3 provider:** GP
**content props encounters 3 diagnosis:** Stable RA; controlled HTN; mild CKD (stable)
**content props encounters 3 medications 0:** Methotrexate 20mg weekly
**content props encounters 3 medications 1:** Folic Acid 5mg weekly
**content props encounters 3 medications 2:** Lisinopril 10mg daily
**content props encounters 3 notes:** Overall well; RA controlled on MTX 20 mg; BP controlled
**content props encounters 4 encounter no:** 5
**content props encounters 4 date:** 2025-06-15
**content props encounters 4 type:** General Practice
**content props encounters 4 provider:** GP
**content props encounters 4 diagnosis:** Acute bacterial sinusitis; RA/HTN/CKD stable
**content props encounters 4 medications 0:** Trimethoprim-Sulfamethoxazole 800/160mg BID
**content props encounters 4 notes:** 5 days nasal congestion, facial pain, headache, green discharge
**content props encounters 5 encounter no:** 6
**content props encounters 5 date:** 2025-06-21
**content props encounters 5 type:** Emergency Medicine
**content props encounters 5 provider:** Dr. Sarah Chen
**content props encounters 5 diagnosis:** Acute liver injury likely DILI and/or severe methotrexate toxicity
**content props encounters 5 notes:** Severe fatigue, jaundice, epigastric pain, confusion
**content props medicationTimeline 0 name:** Methotrexate
**content props medicationTimeline 0 startDate:** 2015-08-10
**content props medicationTimeline 0 endDate:** 2018-09-05
**content props medicationTimeline 0 dose:** 10mg weekly
**content props medicationTimeline 0 indication:** RA
**content props medicationTimeline 1 name:** Methotrexate
**content props medicationTimeline 1 startDate:** 2018-09-05
**content props medicationTimeline 1 dose:** 20mg weekly
**content props medicationTimeline 1 indication:** RA
**content props medicationTimeline 2 name:** Folic Acid
**content props medicationTimeline 2 startDate:** 2015-08-10
**content props medicationTimeline 2 dose:** 5mg weekly
**content props medicationTimeline 2 indication:** MTX supplementation
**content props medicationTimeline 3 name:** Lisinopril
**content props medicationTimeline 3 startDate:** 2018-09-05
**content props medicationTimeline 3 dose:** 10mg daily
**content props medicationTimeline 3 indication:** Hypertension
**content props medicationTimeline 4 name:** Trimethoprim-Sulfamethoxazole
**content props medicationTimeline 4 startDate:** 2025-06-15
**content props medicationTimeline 4 endDate:** 2025-06-25
**content props medicationTimeline 4 dose:** 800/160mg BID
**content props medicationTimeline 4 indication:** Acute bacterial sinusitis
**createdAt:** 2025-10-14T16:47:56.098Z
**updatedAt:** 2025-10-14T16:47:56.098Z

# Object Record 0
**objectId:** dashboard-item-1759853783245-patient-context
**type:** component
**componentType:** PatientContext
**description:** 
**content title:** Patient Context
**content component:** PatientContext
**content props patientData patient name:** Sarah Miller
**content props patientData patient date of birth:** 1962-03-15
**content props patientData patient age:** 63
**content props patientData patient sex:** Female
**content props patientData patient age at first encounter:** 53
**content props patientData patient identifiers mrn:** MC-001001
**content props patientData riskLevel:** high
**content props patientData primaryDiagnosis:** Rheumatoid arthritis
**content props patientData problem list 0 name:** Rheumatoid arthritis
**content props patientData problem list 0 status:** active
**content props patientData problem list 1 name:** Essential hypertension
**content props patientData problem list 1 status:** active
**content props patientData problem list 2 name:** Mild chronic kidney disease
**content props patientData problem list 2 status:** active
**content props patientData medication timeline 0 name:** Methotrexate
**content props patientData medication timeline 0 dose:** 20 mg
**content props patientData medication timeline 0 route:** PO
**content props patientData medication timeline 0 frequency:** weekly
**content props patientData medication timeline 0 start:** 2018-09-05
**content props patientData medication timeline 1 name:** Folic Acid
**content props patientData medication timeline 1 dose:** 5 mg
**content props patientData medication timeline 1 route:** PO
**content props patientData medication timeline 1 frequency:** weekly
**content props patientData medication timeline 1 start:** 2015-08-10
**content props patientData medication timeline 2 name:** Lisinopril
**content props patientData medication timeline 2 dose:** 10 mg
**content props patientData medication timeline 2 route:** PO
**content props patientData medication timeline 2 frequency:** daily
**content props patientData medication timeline 2 start:** 2018-09-05
**content props patientData medication timeline 3 name:** Trimethoprim-Sulfamethoxazole
**content props patientData medication timeline 3 dose:** 800/160 mg
**content props patientData medication timeline 3 route:** PO
**content props patientData medication timeline 3 frequency:** BID
**content props patientData medication timeline 3 start:** 2025-06-15
**content props patientData medication timeline 3 end:** 2025-06-25
**content props patientData allergies 0:** Penicillin (rash)
**createdAt:** 2025-10-14T16:16:23.245Z
**updatedAt:** 2025-10-14T16:16:23.245Z

# Object Record 4
**objectId:** dashboard-item-1759906246156-lab-chart
**type:** component
**componentType:** LabChart
**description:** 
**content title:** Lab Trends
**content component:** LabChart
**content props encounters 0 encounter no:** 1
**content props encounters 0 date:** 2015-08-10
**content props encounters 0 meta ui risk color:** green
**content props encounters 1 encounter no:** 2
**content props encounters 1 date:** 2016-02-20
**content props encounters 1 meta ui risk color:** green
**content props encounters 2 encounter no:** 3
**content props encounters 2 date:** 2018-09-05
**content props encounters 2 meta ui risk color:** green
**content props encounters 3 encounter no:** 4
**content props encounters 3 date:** 2021-03-15
**content props encounters 3 meta ui risk color:** green
**content props encounters 4 encounter no:** 5
**content props encounters 4 date:** 2025-06-15
**content props encounters 4 meta ui risk color:** amber
**content props encounters 5 encounter no:** 6
**content props encounters 5 date:** 2025-06-21
**content props encounters 5 meta ui risk color:** red
**content props encounters 5 meta event tags 0:** Suspected DILI
**content props encounters 5 meta event tags 1:** Potential MTX toxicity
**content props medicationTimeline 0 name:** Methotrexate
**content props medicationTimeline 0 start:** 2015-08-10
**content props medicationTimeline 0 dose:** 10mg weekly
**content props medicationTimeline 1 name:** Methotrexate
**content props medicationTimeline 1 start:** 2018-09-05
**content props medicationTimeline 1 dose:** 20mg weekly
**content props medicationTimeline 2 name:** Lisinopril
**content props medicationTimeline 2 start:** 2018-09-05
**content props medicationTimeline 2 dose:** 10mg daily
**content props medicationTimeline 3 name:** Trimethoprim-Sulfamethoxazole
**content props medicationTimeline 3 start:** 2025-06-15
**content props medicationTimeline 3 end:** 2025-06-25
**content props medicationTimeline 3 dose:** 800/160mg BID
**createdAt:** 2025-10-14T16:50:46.156Z
**updatedAt:** 2025-10-14T16:50:46.156Z

# Object Record 6
**objectId:** raw-nervecentre-encounter-1
**type:** component
**componentType:** RawClinicalNote
**description:** Raw Nervecentre EPR data for Encounter 1
**content title:** Nervecentre - Encounter 1
**content component:** RawClinicalNote
**content props encounterNumber:** 1
**content props date:** 2015-08-10
**content props visitType:** Outpatient Rheumatology
**content props provider:** Dr. Elizabeth Hayes
**content props specialty:** Rheumatology
**content props rawText:** – 2015-08-10, Outpatient Rheumatology (Initial Consult)
Patient: Sarah Miller, 53-year-old female, retired carpenter.
Clinician: Dr. Elizabeth Hayes, Rheumatology.
Chief Complaint: 6-month history of bilateral hand and foot joint pain/swelling.
History of Present Illness: “Progressive, symmetrical pain and swelling in MCPs and PIPs of both hands and 2nd–3rd MTPs of both feet. Severe morning stiffness >1 hour daily and significant fatigue. Tried ibuprofen 200 mg PRN with minimal relief. Symptoms worse in mornings, slightly better with activity. Denies fevers, rash, chest pain, respiratory or GI symptoms, or recent infections.”
Past Medical History: No liver disease. Appendectomy in childhood. No other chronic illnesses.
Medication History: Occasional Ibuprofen 200 mg as needed.
Allergies: None (NKDA).
Family History: Father with hypertension and type 2 diabetes; mother with osteoarthritis. No known autoimmune or liver disease in family.
Social History: Drinks ~1–2 beers/day (7–14 units/week) routinely; denies bingeing. Smokes ~1 pack/day (35 pack-year history). Retired carpenter (exposure to wood dust/solvents). No IV drug use. Married, monogamous.
Review of Systems: Negative for weight loss, fever, or rash. Cardiac and respiratory: no chest pain or cough. GI: no nausea/vomiting/diarrhea. Neuro: no headaches or focal deficits. MSK: (as above).
Physical Exam: Alert, fatigued but NAD. Vitals WNL. HEENT normal. Neck supple, no lymphadenopathy. Heart: RRR, no murmurs. Lungs clear. Abdomen soft, NTND, no hepatosplenomegaly. Skin: no rash or jaundice. MSK: Hands – visibly swollen, tender MCP joints (2nd–3rd) and PIP joints (2nd–3rd) bilaterally; similar swelling in both 2nd–3rd MTP joints. Palpable synovitis and warmth. Reduced grip strength. Range-of-motion limited by pain. No joint deformities yet. No subcutaneous nodules.
Assessment: Likely Seropositive Rheumatoid Arthritis, active. Differential: Psoriatic arthritis, SLE, gout/pseudogout.
Plan:
Investigations: Order Rheumatoid Factor, anti-CCP IgG, ESR, CRP, CBC with diff, LFTs (AST, ALT, ALP, bilirubin), creatinine/eGFR, Hep B serologies (HBsAg, anti-HBc total) and Hep C antibody.
Medications: Start Methotrexate 10 mg PO once weekly + Folic Acid 5 mg PO weekly (to be taken the day after MTX). Discuss MTX side effects.
Patient Education: Explained RA pathophysiology, chronic nature, and treatment goals. Counseling on MTX: common side effects (malaise, GI upset, mucositis) and serious risks (hepatotoxicity, bone marrow suppression, lung toxicity). Emphasized need for strict alcohol avoidance with MTX. Advised regular blood test monitoring. Reinforced smoking cessation (“greatest modifiable risk”).
Referrals: Rheumatology nurse to provide MTX information/monitoring. Smoking cessation support provided.
Follow-Up: Return to Rheumatology clinic in 3 months. GP to check CBC, LFTs, renal, ESR/CRP in 4 weeks. “Red flag” symptoms (fever, severe fatigue, rash, jaundice) to prompt urgent evaluation.
Coding: ICD-10 M05.9 (Seropositive RA, unspecified); CPT 99204 (New patient, moderate complexity).
**content props dataSource:** Nervecentre EPR
**createdAt:** 2025-10-17T03:32:13.025Z
**updatedAt:** 2025-10-17T03:32:13.025Z

# Object Record 3
**objectId:** dashboard-item-1759906300004-single-encounter-4
**type:** component
**componentType:** SingleEncounterDocument
**description:** 
**content title:** Encounter #4 - Outpatient (Chronic Review)
**content component:** SingleEncounterDocument
**content props encounter encounter no:** 4
**content props encounter meta visit type:** Outpatient
**content props encounter meta date time:** 2021-03-15T09:00:00
**content props encounter meta provider name:** None
**content props encounter meta provider specialty:** General Practice
**content props encounter meta ui risk color:** green
**content props encounter reason for visit:** Routine chronic disease review (RA, HTN)
**content props encounter chief complaint:** Routine follow-up for RA/HTN
**content props encounter hpi:** Overall well; RA controlled on MTX 20 mg; BP controlled on Lisinopril; occasional low back pain; eGFR mildly declined but stable; continues 1–2 beers/day.
**content props encounter medications prior 0 name:** Methotrexate
**content props encounter medications prior 0 dose:** 20 mg
**content props encounter medications prior 0 route:** PO
**content props encounter medications prior 0 frequency:** weekly
**content props encounter medications prior 1 name:** Folic Acid
**content props encounter medications prior 1 dose:** 5 mg
**content props encounter medications prior 1 route:** PO
**content props encounter medications prior 1 frequency:** weekly (next day after MTX)
**content props encounter medications prior 2 name:** Lisinopril
**content props encounter medications prior 2 dose:** 10 mg
**content props encounter medications prior 2 route:** PO
**content props encounter medications prior 2 frequency:** daily
**content props encounter medications prior 3 name:** Paracetamol
**content props encounter medications prior 3 dose:** None
**content props encounter medications prior 3 route:** PO
**content props encounter medications prior 3 frequency:** PRN
**content props encounter physical exam general:** Fit/well
**content props encounter physical exam vitals:** BP 130/82, HR 68, RR 16, Temp 36.7°C
**content props encounter physical exam msk:** No synovitis
**content props encounter physical exam abdomen:** Soft, non-tender
**content props encounter assessment impression:** Stable RA; controlled HTN; chronic mild low back pain; mild CKD (stable)
**content props encounter plan investigations labs 0:** CBC
**content props encounter plan investigations labs 1:** LFTs
**content props encounter plan investigations labs 2:** Creatinine
**content props encounter plan investigations labs 3:** eGFR
**content props encounter plan management education 0:** Continue MTX 20 mg weekly, Folic Acid 5 mg weekly, Lisinopril 10 mg daily
**content props encounter plan management education 1:** Hydration importance with CKD and ACE inhibitor
**content props encounter plan management education 2:** Alcohol moderation reinforced
**content props patient name:** Sarah Miller
**content props patient sex:** Female
**content props patient age at first encounter:** 53
**content props encounterIndex:** 3
**content props dataSource:** ICE
**createdAt:** 2025-10-15T08:00:00.000Z
**updatedAt:** 2025-10-15T08:00:00.000Z

# Object Record 11
**objectId:** raw-nervecentre-encounter-6
**type:** component
**componentType:** RawClinicalNote
**description:** Raw Nervecentre EPR data for Encounter 6
**content title:** Nervecentre - Encounter 6
**content component:** RawClinicalNote
**content props encounterNumber:** 6
**content props date:** 2025-06-21
**content props visitType:** Emergency Dept
**content props provider:** Dr. Sarah Chen
**content props specialty:** Emergency Medicine
**content props rawText:** – 2025-06-21, Emergency Dept (Severe Jaundice & Fatigue)
Patient: Sarah Miller, 63 y/o. Brought in by wife for acute jaundice, confusion, and epigastric pain.
Clinician: Dr. Sarah Chen, Emergency Medicine.
Presenting Complaint: 24-hour history of extreme tiredness, yellow eyes/skin, upper abdomen pain, nausea. Recent TMP-SMX for sinusitis (started 6 days ago). Mild mouth ulcers noted 4–6 days ago. No fever or GI bleeding. No other new meds.
Past History: Rheumatoid arthritis (10 years, on MTX), Hypertension (7 years), chronic back pain, CKD Stage 3 (eGFR ~55). No known liver disease. Appendectomy as a child.
Medications: MTX 20 mg weekly (Mon), Folic Acid 5 mg weekly (Tue), Lisinopril 10 mg daily, TMP-SMX 800/160 mg BID ×6d, Paracetamol PRN. Allergies: Penicillin (rash).
Review of Systems: Significant for nausea, anorexia, dark urine. No cough/dyspnea. Altered mental status (mild confusion).
Physical Exam: Ill, jaundiced, drowsy (GCS 13). Vitals: BP 142/90, HR 75, RR 18, T 36.9°C. Neuro: Arousable but disoriented; asterixis present. Abd: Soft, mild epigastric tenderness, no HSM or ascites. Skin: Generalized icterus, oral mucosa with small ulcers. No rash or bruises.
Impression: Acute severe liver injury (likely drug-induced: MTX toxicity ± TMP-SMX). Possible methotrexate overdose or fulminant hepatitis. DDX: acute viral hepatitis, Wilson’s, sepsis.
Plan: Admit to ICU. STAT labs: CBC (for cytopenias), Comprehensive Metabolic Panel (LFTs, renal), PT/INR, Ammonia, Serum MTX level, viral hepatitis serologies (HAV IgM, HBsAg/IgM, HCV Ab), autoimmune serologies, toxicology. STAT abdominal ultrasound (liver appearance, biliary). Start IV fluids and IV N-acetylcysteine (covering for DILI/acute liver failure). NPO, frequent neuro checks. Notify GI/Hepatology and Hematology. Prepare for possible transfusions or dialysis.
Orders/Results: (via ICE/EHR) STAT lab draw sent.
Coding: ICD-10 K71.1 (Toxic liver disease with hepatic necrosis), T45.1X5A (Adverse effect of MTX), T36.0X5A (Adverse effect of sulfonamides). CPT 99285 (ED high complexity).
**content props dataSource:** Nervecentre EPR
**createdAt:** 2025-10-17T03:32:13.025Z
**updatedAt:** 2025-10-17T03:32:13.025Z